A manufacturer brings a device to a new specialty distributor. The partnership starts well. The distributor's representatives are trained, credentialed, and clinically prepared. The product gets in front of surgeons. The first few cases go ahead. Then adoption stalls. Not because the device is inferior, and not because the distributor failed to represent it. Because the manufacturer arrived at the partnership without the clinical support infrastructure that turns a capable distributor into a productive one.

The most avoidable failures in distribution partnerships are not failures of the product or the distributor. They are failures of preparation. Understanding what a specialty distributor needs from a manufacturer before day one is the starting point for a partnership that performs.

The clinical training package that enables your distributor to sell credibly

A medical sales consultant who has received a product walkthrough is not the same as one who has received a clinical training package. The difference is the depth of material. A training package that covers the device indication criteria, the anatomical context of the procedure, the technique steps with the surgeon's perspective included, the published clinical evidence, and the most common intraoperative questions and their answers produces a representative who can hold a clinical conversation with a surgeon.

Before your product enters Synchrocare's portfolio, prepare a training package at that standard. Not a brochure and a spec sheet. A comprehensive clinical resource that gives every medical sales consultant the foundation to represent your device the way it deserves to be represented. That investment in pre-launch preparation compounds across every case your distributor supports.

The manufacturers who get the most from a distribution partnership are the ones who invest in making their distributor as clinically prepared as their own direct team.

The clinical data your distributor needs to navigate adoption conversations

Every surgeon a medical sales consultant meets will ask some version of the same question: What does the evidence say? A representative who cannot answer that question with a peer-reviewed publication, a clinical outcomes summary, or, at a minimum, a clear description of the study design behind the product's claims, loses credibility in the room that is hardest to recover.

Provide your distributor with the clinical evidence in a format that is accessible and presentable in a surgeon conversation, not just in a regulatory filing. Published studies, clinical outcome summaries, case study data, and technique papers that illustrate real-world performance all contribute to the clinical case your distributor makes on your behalf. If the evidence is limited, be transparent about what exists and what is in development. A distributor who can speak honestly about the evidence base builds more durable surgeon trust than one who overstates it.

The support infrastructure that keeps adoption moving after the first case

The first case is the beginning of adoption, not the end of it. Post-launch support infrastructure determines whether a surgeon's first positive experience with your device leads to a second case, a third, and eventual integration into their standard practice. That infrastructure includes technique guides, FAQs, case study resources, and a clear escalation path for clinical questions that arise in the field.

Synchrocare provides this post-sale support infrastructure as standard across every product in its portfolio. The manufacturer's responsibility is to supply the clinical content that the infrastructure delivers. A manufacturer who treats the distribution agreement as the finish line rather than the starting line of their launch investment will find adoption stalls at the same point every time, after the first few cases and before the device becomes embedded in surgical practice.

To learn more about partnering with Synchrocare as your specialty distribution partner, visit www.synchrocare.com.